LH vs. CNMD: Which Stock Is the Better Value Option? Zacks Equity Research - Zacks Investment Research - Wed Jul 17, 8:30AM CDT Zacks Equity Research - ZACKS - Wed Jul 17, 8:30AM CDT
LH vs. CNMD: Which Stock Is the Better Value Option?
37.0% Return Seen to Date on SmarTrend Conmed Corp Call (CNMD) Comtex SmarTrend(R) - Tue Jul 16, 12:20AM CDT CMTX - Tue Jul 16, 12:20AM CDT
SmarTrend identified an Uptrend for Conmed Corp (NASDAQ:CNMD) on December 31st, 2018 at $63.09. In approximately 7 months, Conmed Corp has returned 36.98% as of today's recent price of $86.42.
Conmed Corp Up 37.3% Since SmarTrend Uptrend Call (CNMD) Comtex SmarTrend(R) - Mon Jul 8, 1:21PM CDT CMTX - Mon Jul 8, 1:21PM CDT
SmarTrend identified an Uptrend for Conmed Corp (NASDAQ:CNMD) on December 31st, 2018 at $63.09. In approximately 6 months, Conmed Corp has returned 37.30% as of today's recent price of $86.62.
Here's Why You Should Invest in CONMED (CNMD) Stock Now Zacks Equity Research - Zacks Investment Research - Thu Jul 4, 8:06AM CDT Zacks Equity Research - ZACKS - Thu Jul 4, 8:06AM CDT
CONMED (CNMD) continues to benefit from robust international sales, broad product portfolio and persistent focus on R&D.
Myriad Genetics' Elevate 2020 Plan Holds Promise Amid Issues Zacks Equity Research - Zacks Investment Research - Tue Jul 2, 1:55PM CDT Zacks Equity Research - ZACKS - Tue Jul 2, 1:55PM CDT
Myriad Genetics (MYGN) unveils an 'Elevate 2020' program that aims to generate $50 million in incremental operating income by fiscal 2020.
Medtronic's Titan Spine Buyout to Boost Spine Surgery Range Zacks Equity Research - Zacks Investment Research - Tue Jul 2, 8:15AM CDT Zacks Equity Research - ZACKS - Tue Jul 2, 8:15AM CDT
Medtronic's (MDT) comprehensive biologics portfolio clubbed with Titan Spine's surface-enhanced titanium implants can enhance patient outcomes in spinal procedures.
Walgreens Gains on Strategic Deals, Margin Pressure Remains Zacks Equity Research - Zacks Investment Research - Mon Jul 1, 7:36AM CDT Zacks Equity Research - ZACKS - Mon Jul 1, 7:36AM CDT
Walgreens Boots' (WBA) Retail Pharmacy USA division is witnessing comparable prescription growth and also benefiting from a strong retail prescription market.
Thermo Fisher's Unit Sale May Not Ail Specialty Diagnostics Zacks Equity Research - Zacks Investment Research - Mon Jul 1, 7:31AM CDT Zacks Equity Research - ZACKS - Mon Jul 1, 7:31AM CDT
The Anatomical Pathology business of Thermo Fisher (TMO) belongs to its Specialty Diagnostics segment that serves customers across healthcare and clinical laboratories.
Here's Why You Should Hold Varian Medical (VAR) Stock Now Zacks Equity Research - Zacks Investment Research - Mon Jul 1, 7:12AM CDT Zacks Equity Research - ZACKS - Mon Jul 1, 7:12AM CDT
Varian (VAR) expects the Cancer Treatment Services International buyout to prove accretive to earnings per share during fiscal 2021.
Conmed Corp Up 37.2% Since SmarTrend Uptrend Call (CNMD) Comtex SmarTrend(R) - Fri Jun 28, 1:05PM CDT CMTX - Fri Jun 28, 1:05PM CDT
SmarTrend identified an Uptrend for Conmed Corp (NASDAQ:CNMD) on December 31st, 2018 at $63.09. In approximately 6 months, Conmed Corp has returned 37.22% as of today's recent price of $86.57.
Amedisys Rides on New Buyouts, Strength in Personal Care Arm Zacks Equity Research - Zacks Investment Research - Fri Jun 28, 8:53AM CDT Zacks Equity Research - ZACKS - Fri Jun 28, 8:53AM CDT
Amedisys' (AMED) recently-integrated Personal Care segment is attaining stability and living up to expectation.
Veeva's Vault eTMF Implemented by South Korea's Celltrion Zacks Equity Research - Zacks Investment Research - Fri Jun 28, 7:36AM CDT Zacks Equity Research - ZACKS - Fri Jun 28, 7:36AM CDT
Management at Veeva (VEEV) expects Vault subscription revenues to grow a significant 40% in fiscal 2020.
Patterson Companies' (PDCO) Earnings Miss Estimates in Q4 Zacks Equity Research - Zacks Investment Research - Thu Jun 27, 8:44AM CDT Zacks Equity Research - ZACKS - Thu Jun 27, 8:44AM CDT
Patterson Companies' (PDCO) Q4 results benefit from higher revenues, gross margin expansion and solid show by Animal Health segment.
Varian (VAR) & Tennessee Oncology to Implement Use of Noona Zacks Equity Research - Zacks Investment Research - Thu Jun 27, 7:53AM CDT Zacks Equity Research - ZACKS - Thu Jun 27, 7:53AM CDT
Varian's (VAR) core Oncology unit gets a boost from the latest collaboration with Tennessee Oncology.
Here's Why You Should Invest in DENTSPLY SIRONA (XRAY) Now Zacks Equity Research - Zacks Investment Research - Wed Jun 26, 7:04AM CDT Zacks Equity Research - ZACKS - Wed Jun 26, 7:04AM CDT
DENTSPLY (XRAY) focuses on innovation through active R&D.
Veeva's Submissions & RIM Implemented by Sumitomo Dainippon Zacks Equity Research - Zacks Investment Research - Wed Jun 26, 7:00AM CDT Zacks Equity Research - ZACKS - Wed Jun 26, 7:00AM CDT
Veeva's (VEEV) flagship Vault platform witnesses robust demand.
Here's Why You Should Buy Masimo (MASI) Stock Right Now Zacks Equity Research - Zacks Investment Research - Mon Jun 24, 7:21AM CDT Zacks Equity Research - ZACKS - Mon Jun 24, 7:21AM CDT
Masimo (MASI) receives FDA clearance for its O3 Regional Oximetry for utilization on neonatal and infant patients.
Conmed Corp Has Returned 36.5% Since SmarTrend Recommendation (CNMD) Comtex SmarTrend(R) - Fri Jun 21, 12:25AM CDT CMTX - Fri Jun 21, 12:25AM CDT
SmarTrend identified an Uptrend for Conmed Corp (NASDAQ:CNMD) on December 31st, 2018 at $63.09. In approximately 6 months, Conmed Corp has returned 36.47% as of today's recent price of $86.10.
Cooper Companies (COO) Q2 Earnings & Revenues Top Estimates Zacks Equity Research - Zacks Investment Research - Fri May 31, 7:53AM CDT Zacks Equity Research - ZACKS - Fri May 31, 7:53AM CDT
Higher revenues, solid segmental performance and expansion in margins benefit Cooper Companies' (COO) Q2 earnings.
Veeva Systems (VEEV) Q1 Earnings Top Estimates, View Strong Zacks Equity Research - Zacks Investment Research - Thu May 30, 7:19AM CDT Zacks Equity Research - ZACKS - Thu May 30, 7:19AM CDT
Veeva Systems (VEEV) issues strong guidance for fiscal 2020.
